Table 1 Epidemiologic criteria of the studied group and the survival of the patients
From: Hepatocellular carcinoma associated other primaries: common types and prognosis
Variable | Value |
|---|---|
Age at HCC diagnosis (mean ± SD) | 63.3 ± 10.8 kg/m2 |
Sex | |
Male | 7 (46.7%) |
Female | 8 (53.3%) |
Timing of second malignancy | |
Synchronous | 5 (33.3%) |
Metachronous | 10 (66.7%) |
First malignancy in the metachronous patients | |
HCC first | 3 (30%)a |
Other mg first | 7 (70%)a |
Type of the second primary with HCC | |
Breast cancer | 5 (33.3%) |
Basal cell carcinoma | 3 (20%) |
Squamous cell carcinoma | 1 (6.7%) |
Non-Hodgkin lymphoma | 1 (6.7%) |
Papillary thyroid cancer | 1 (6.7%) |
Liposarcoma | 1 (6.7%) |
Prostate cancer | 1 (6.7%) |
Paraganglioma | 1 (6.7%) |
Mucinous neoplasm (ovary + appendix) | 1 (6.7%) |
Time interval between HCC and the other metachronous tumor median (range) | − 12 (− 102–19) months |
Estimated overall survival | |
Mean (95%CI) | 43.5 (23.9–63.2) months |
Median (95%CI) | 29 (12–46) months |
Estimated disease-free survival mean (95%CI) | 7.2 (2.2–12.2) months |